Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals
Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals
复制标题
DOI：
10.1111/j.1525-1497.2006.00598.x
复制
发表时间：
2006-12-01
影响因子：
5.7
通讯作者：
Hoffman, Jerome R.
中科院分区：
文献类型：
--
作者：
Cooper, Richelle J.;Gupta, Malkeet;Hoffman, Jerome R.
目的：我们进行了这项调查，以描述利益冲突（COI）的政策，生物医学期刊的作者，同行评审员和编辑，并确定什么样的信息COI披露是公开的。方法：我们进行了一项横断面调查的便利样本135同行评审的生物医学期刊的编辑，发表原创性研究。我们选择了一系列以英语出版的国际通用和专业医学期刊。选择基于期刊影响因子和该领域专家的建议。我们开发并试点测试了一个由三部分组成的基于网络的调查。调查包括关于作者、同行评审员和编辑的具体政策的存在，基于COI对作者、同行评审员和编辑的具体限制，以及这些披露的公开可用性。编辑联系了最少3 times.Results：调查的回应率为91（67%）的135，和85（93%）的91种期刊报告有作者COI政策。10种（11%）期刊报告说，他们根据COI限制作者投稿（例如，不接受制药公司作者关于其产品的论文）。虽然77%的人报告收集所有作者提交的COI信息，但只有57%的人公布了所有作者披露的信息。少数期刊报告对同行评审员（46%（42/91））或编辑COI（40%（36/91））有具体政策;其中，25%和31%的期刊表示，如果他们报告COI，他们需要同行评审员和编辑回避。只有3%的受访者发表同行评审COI披露，12%的出版编辑COI披露，而11%和24%，分别报告说，这些信息是可应要求提供的。结论：更多的期刊有关于COI的政策，作者比他们的同行评审或编辑。甚至作者的COI政策也是可变的，这取决于提交的手稿类型。期刊收集的COI信息通常不会被公布;这种“秘密披露”可能会在多大程度上影响期刊或已发表作品的完整性尚不清楚。
OBJECTIVE: We undertook this investigation to characterize conflict of interest (COI) policies of biomedical journals with respect to authors, peer-reviewers, and editors, and to ascertain what information about COI disclosures is publicly available.METHODS: We performed a cross-sectional survey of a convenience sample of 135 editors of peer-reviewed biomedical journals that publish original research. We chose an international selection of general and specialty medical journals that publish in English. Selection was based on journal impact factor, and the recommendations of experts in the field. We developed and pilot tested a 3-part web-based survey. The survey included questions about the presence of specific policies for authors, peer-reviewers, and editors, specific restrictions on authors, peer-reviewers, and editors based on COI, and the public availability of these disclosures. Editors were contacted a minimum of 3 times.RESULTS: The response rate for the survey was 91 (67%) of 135, and 85 (93%) of 91 journals reported having an author COI policy. Ten (11%) journals reported that they restrict author submissions based on COI (e.g., drug company authors' papers on their products are not accepted). While 77% report collecting COI information on all author submissions, only 57% publish all author disclosures. A minority of journals report having a specific policy on peer-reviewer 46% (42/91) or editor COI 40% (36/91); among these, 25% and 31% of journals state that they require recusal of peer-reviewers and editors if they report a COI. Only 3% of respondents publish COI disclosures of peer-reviewers, and 12% publish editor COI disclosures, while 11% and 24%, respectively, reported that this information is available upon request.CONCLUSION: Many more journals have a policy regarding COI for authors than they do for peer-reviewers or editors. Even author COI policies are variable, depending on the type of manuscript submitted. The COI information that is collected by journals is often not published; the extent to which such "secret disclosure" may impact the integrity of the journal or the published work is not known.